The cytotoxicity of aflatoxin B1 in human lymphocytes

Suleiman Al-Hammadi, Farida Marzouqi, Aysha Al-Mansouri, Allen Shahin, Mariam Al-Shamsi, Eric Mensah-Brown, Abdul Kader Souid

Research output: Contribution to journalArticlepeer-review

16 Citations (Scopus)


Objectives: Aflatoxin B1 (AFB1) is a naturally occurring carcinogenic and immunosuppressive compound. This study was designed to measure its toxic effects on human peripheral blood mononuclear cells (PBMC). Methods: The study recruited 7 healthy volunteers. PBMC were isolated and cellular respiration was monitored using a phosphorescence oxygen analyser. The intracellular caspase activity was measured by the caspase-3 substrate N-acetyl-asp-glu-val-asp-7-amino-4-methylcoumarin. Phosphatidylserine exposure and membrane permeability to propidium iodide (PI) were measured by flow cytometry. Results: Cellular oxygen consumption was inhibited by 2.5 μM and 25 μM of AFB1. Intracellular caspase activity was noted after two hours of incubation with 100 μM of AFB1. The number of Annexin V-positive cells increased as a function of AFB1 concentration and incubation time. At 50 μM, a significant number of cells became necrotic after 24 hours (Annexin V-positive and PI-positive). Conclusion: The results show AFB1 is toxic to human lymphocytes and that its cytotoxicity is mediated by apoptosis and necrosis.

Original languageEnglish
Pages (from-to)e65-e71
JournalSultan Qaboos University Medical Journal
Issue number1
Publication statusPublished - Jan 2014


  • Caspases
  • Cellular respiration
  • Leukocytes
  • Mitochondria
  • Mononuclear
  • Oxygen analyzer

ASJC Scopus subject areas

  • General Medicine


Dive into the research topics of 'The cytotoxicity of aflatoxin B1 in human lymphocytes'. Together they form a unique fingerprint.

Cite this